Related Experiment Video
Updated: Mar 7, 2026

Intracranial Pressure Monitoring In Nontraumatic Intraventricular Hemorrhage Rodent Model
Published on: February 8, 2022
Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update
Sang Joon An1, Tae Jung Kim1, Byung-Woo Yoon1
1Department of Neurology, Seoul National University Hospital, Seoul, Korea.
Insights
Intracerebral hemorrhage (ICH) is a severe stroke subtype with high fatality. Understanding risk factors like hypertension and anticoagulation use is crucial for managing this critical condition.
Area of Science:
- Neurology
- Vascular Neurology
- Public Health
Background:
- Intracerebral hemorrhage (ICH) is a major cause of stroke-related disability and death.
- ICH disproportionately affects certain demographics, including Asians, older adults, and males, particularly in low- and middle-income countries.
- High case fatality rates and limited functional independence in survivors underscore the critical nature of ICH.
Purpose of the Study:
- To summarize the epidemiology, risk factors, clinical presentation, and emerging management challenges of intracerebral hemorrhage.
- To highlight the increasing incidence of anticoagulation-related ICH and the need for strategies for novel oral anticoagulants.
Main Methods:
- Review of existing literature on intracerebral hemorrhage.
- Analysis of demographic data, risk factors, and clinical outcomes associated with ICH.
- Examination of trends in anticoagulation use and associated ICH management.
Main Results:
- Key risk factors for ICH include hypertension, smoking, alcohol consumption, and hypocholesterolemia.
- Advanced age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) are significant risk factors.
- Clinical presentation is variable, influenced by hematoma size, location, and intraventricular extension; CAA-related ICH often presents with cognitive impairment.
Conclusions:
- ICH is a critical neurological emergency with significant mortality and morbidity.
- Emerging challenges include managing anticoagulation-related ICH, particularly with the increasing use of non-vitamin K antagonist oral anticoagulants (NOACs).
- Further research and clinical strategies are needed to address the growing burden of NOAC-associated ICH.
Abstract:
Intracerebral hemorrhage (ICH) is the second most common subtype of stroke and a critical disease usually leading to severe disability or death. ICH is more common in Asians, advanced age, male sex, and low- and middle-income countries. The case fatality rate of ICH is high (40% at 1 month and 54% at 1 year), and only 12% to 39% of survivors can achieve long-term functional independence. Risk factors of ICH are hypertension, current smoking, excessive alcohol consumption, hypocholesterolemia, and drugs. Old age, male sex, Asian ethnicity, chronic kidney disease, cerebral amyloid angiopathy (CAA), and cerebral microbleeds (CMBs) increase the risk of ICH. Clinical presentation varies according to the size and location of hematoma, and intraventricular extension of hemorrhage. Patients with CAA-related ICH frequently have concomitant cognitive impairment. Anticoagulation related ICH is increasing recently as the elderly population who have atrial fibrillation is increasing. As non-vitamin K antagonist oral anticoagulants (NOACs) are currently replacing warfarin, management of NOAC-associated ICH has become an emerging issue.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

